Biomerieux, a global leader in in vitro diagnostics, has a significant presence in Africa, contributing to healthcare improvements across the continent. While exact revenue figures specific to Africa are not publicly disclosed, we can infer their financial performance through various indicators and company reports.

In 2021, Biomerieux reported overall revenues of approximately €3.1 billion (around $3.6 billion), with a growing portion attributed to emerging markets, including Africa. The company has been expanding its operations in Africa to enhance diagnostic capabilities in countries like South Africa, Nigeria, and Kenya, which are pivotal markets for healthcare innovation.

For example, in South Africa, Biomerieux has partnered with local health authorities to provide advanced diagnostic solutions for infectious diseases, which are prevalent in the region. This partnership is not only aimed at improving patient outcomes but also at capturing a larger market share in the diagnostics sector.

In 2020, Biomerieux launched a new diagnostic platform specifically designed for use in African healthcare settings, which illustrates their commitment to investing in the continent. The platform is expected to significantly increase their revenue streams in the region as healthcare providers adopt these advanced technologies.

Moreover, Biomerieux's initiatives in Africa align with the continent's growing demand for diagnostic solutions, particularly in response to the COVID-19 pandemic. The company has played a crucial role in supplying COVID-19 testing kits and equipment to various African countries, further solidifying its market position.

While specific revenue figures for Africa remain elusive, industry experts estimate that Biomerieux's growth in the region could contribute tens of millions of euros annually, especially as they continue to expand their product offerings and partnerships.

For more detailed information, you may refer to Biomerieux's annual reports and press releases, which provide insights into their financial performance and strategic initiatives in various regions, including Africa. Additionally, industry analysis from sources like ResearchGate can shed light on the broader context of diagnostics in Africa.